CY1108090T1 - Επαυξηση και αυξηση ογκου μαλακου ιστου και οστου χρησιμοποιωντας μυο-λαμβανομενα προγονα κυτταρα, συνθεσεις και θεραπειες αυτων - Google Patents

Επαυξηση και αυξηση ογκου μαλακου ιστου και οστου χρησιμοποιωντας μυο-λαμβανομενα προγονα κυτταρα, συνθεσεις και θεραπειες αυτων

Info

Publication number
CY1108090T1
CY1108090T1 CY20071100849T CY071100849T CY1108090T1 CY 1108090 T1 CY1108090 T1 CY 1108090T1 CY 20071100849 T CY20071100849 T CY 20071100849T CY 071100849 T CY071100849 T CY 071100849T CY 1108090 T1 CY1108090 T1 CY 1108090T1
Authority
CY
Cyprus
Prior art keywords
mdcs
growth
muscle
soft tissue
compositions
Prior art date
Application number
CY20071100849T
Other languages
Greek (el)
English (en)
Inventor
Michael B Chancellor
Johnny Huard
Christopher C Capelli
Zhuqing Qu
Original Assignee
University Of Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24195003&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1108090(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/549,937 external-priority patent/US7115417B1/en
Application filed by University Of Pittsburgh filed Critical University Of Pittsburgh
Publication of CY1108090T1 publication Critical patent/CY1108090T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • C12N5/0659—Satellite cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
CY20071100849T 2000-04-14 2007-06-28 Επαυξηση και αυξηση ογκου μαλακου ιστου και οστου χρησιμοποιωντας μυο-λαμβανομενα προγονα κυτταρα, συνθεσεις και θεραπειες αυτων CY1108090T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/549,937 US7115417B1 (en) 1998-05-01 2000-04-14 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenito compositions, and treatments thereof
EP01924998A EP1272204B1 (en) 2000-04-14 2001-04-12 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof

Publications (1)

Publication Number Publication Date
CY1108090T1 true CY1108090T1 (el) 2014-02-12

Family

ID=24195003

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100849T CY1108090T1 (el) 2000-04-14 2007-06-28 Επαυξηση και αυξηση ογκου μαλακου ιστου και οστου χρησιμοποιωντας μυο-λαμβανομενα προγονα κυτταρα, συνθεσεις και θεραπειες αυτων

Country Status (13)

Country Link
US (3) US9499791B2 (cg-RX-API-DMAC7.html)
EP (1) EP1272204B1 (cg-RX-API-DMAC7.html)
JP (2) JP5684963B2 (cg-RX-API-DMAC7.html)
AT (1) ATE365045T1 (cg-RX-API-DMAC7.html)
AU (2) AU2001251599B2 (cg-RX-API-DMAC7.html)
CA (1) CA2406393C (cg-RX-API-DMAC7.html)
CY (1) CY1108090T1 (cg-RX-API-DMAC7.html)
DE (1) DE60129007T2 (cg-RX-API-DMAC7.html)
DK (1) DK1272204T3 (cg-RX-API-DMAC7.html)
ES (1) ES2288946T3 (cg-RX-API-DMAC7.html)
HK (1) HK1052645B (cg-RX-API-DMAC7.html)
PT (1) PT1272204E (cg-RX-API-DMAC7.html)
WO (1) WO2001078754A2 (cg-RX-API-DMAC7.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485723B1 (en) 1995-02-10 2002-11-26 Purdue Research Foundation Enhanced submucosal tissue graft constructs
US6866842B1 (en) 1998-05-01 2005-03-15 University Of Pittsburgh Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction
US7115417B1 (en) 1998-05-01 2006-10-03 Chancellor Michael B Soft tissue and bone augmentation and bulking utilizing muscle-derived progenito compositions, and treatments thereof
EP1272204B1 (en) 2000-04-14 2007-06-20 University of Pittsburgh Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
EP1372398B1 (en) * 2001-02-23 2013-07-10 The University of Pittsburgh Rapid preparation of stem cell matrices for use in tissue and organ treatement and repair
US20030082153A1 (en) * 2001-10-22 2003-05-01 The Government Of The United States Of America Stem cells that transform to beating cardiomyocytes
AU2003234317B2 (en) 2002-05-02 2009-04-09 Purdue Research Foundation Vascularization enhanced graft constructs
CN1684589A (zh) 2002-05-02 2005-10-19 普渡研究基金会 血管化增强的移植构造物
WO2003092471A2 (en) 2002-05-02 2003-11-13 Cook Biotech Incorporated Cell-seeded extracellular matrix grafts
EP1503789A4 (en) 2002-05-02 2006-08-02 Purdue Research Foundation IMPROVED VASCULARIZATION BY GRAFT CONSTRUCTIONS
JP4764626B2 (ja) * 2002-05-06 2011-09-07 ベクトン・ディキンソン・アンド・カンパニー 薬剤の薬物動力学を制御する方法およびデバイス
US20060057119A1 (en) * 2002-08-23 2006-03-16 Law Peter K Biologic skin repair and enhancement
DE602004029349D1 (de) * 2003-04-25 2010-11-11 Univ Pittsburgh Von muskeln stammende zellen (mdcs) zur förderung und verbesserung der nervenreparatur und -regeneration
US20050148512A1 (en) 2003-11-10 2005-07-07 Angiotech International Ag Medical implants and fibrosis-inducing agents
WO2005070439A1 (en) * 2004-01-09 2005-08-04 Regeneration Technologies Inc. Implant comprising a human muscle tissue matrix
US7001430B2 (en) 2004-01-09 2006-02-21 Regeneration Technologies, Inc. Matrix composition for human grafts/implants
WO2005070328A1 (en) 2004-01-09 2005-08-04 Regeneration Technologies, Inc. Muscle-based grafts/implants
CA2607975A1 (en) * 2005-05-30 2006-12-07 Commonwealth Scientific And Industrial Research Organisation Preparation and use of basement membrane particles
US20070065415A1 (en) * 2005-09-16 2007-03-22 Kleinsek Donald A Compositions and methods for the augmentation and repair of defects in tissue
US7815923B2 (en) 2005-12-29 2010-10-19 Cook Biotech Incorporated Implantable graft material
JP5395672B2 (ja) * 2006-11-28 2014-01-22 ユニバーシティー オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション 心臓病理学を処置するための筋肉由来の細胞およびその作製法および使用法
US20100158875A1 (en) 2006-12-18 2010-06-24 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Muscle derived cells for the treatment of gastro-esophageal pathologies and methods of making and using the same
WO2008076435A1 (en) * 2006-12-18 2008-06-26 University Of Pittsburgh Muscle derived cells for the treatment of gastro-esophageal pathologies and methods of making and using the same
WO2008086040A1 (en) 2007-01-11 2008-07-17 University Of Pittsburgh Muscle derived cells for the treatment of urinary tract pathologies and methods of making and using the same
AU2008263134B2 (en) * 2007-05-29 2014-06-19 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Bone augmentation utilizing muscle-derived progenitor compositions, and treatments thereof
EP2209482A4 (en) * 2007-10-04 2016-06-01 Univ Pittsburgh SKELETAL MUSCLE REINFORCEMENT WITH MUSCLE PRESERVATORY COMPOSITIONS AND TREATMENTS THEREOF
CA2734858C (en) 2008-08-18 2019-01-15 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof
US20130123647A1 (en) 2011-05-03 2013-05-16 The Research Foundation Of State University Of New York Methods Useful in Optimizing the Treatment of Neuropathies and Targeting Tissues with Cosmetic Botulinum Injections
US9878071B2 (en) 2013-10-16 2018-01-30 Purdue Research Foundation Collagen compositions and methods of use
EP3185922B1 (en) 2014-08-27 2025-04-02 Purdue Research Foundation Collagen-based therapeutic delivery systems
WO2016172365A1 (en) 2015-04-21 2016-10-27 Purdue Research Foundation Office Of Technology Commercialization Cell-collagen-silica composites and methods of making and using the same
JP7242553B2 (ja) 2017-01-31 2023-03-20 ジェニフィス，インコーポレイテッド 基質の調製のための方法及び組成物
WO2018200750A1 (en) 2017-04-25 2018-11-01 Purdue Research Foundation 3-dimensional (3d) tissue-engineered muscle for tissue restoration
WO2019115790A1 (en) 2017-12-14 2019-06-20 Innovacell Biotechnologie Ag Methods for obtaining muscle derived cells
EP3942020B1 (en) 2019-03-22 2024-05-15 Innovacell GmbH Methods for obtaining induced smooth muscle cells
EP3778875A1 (en) * 2019-08-14 2021-02-17 MaxiVax SA Immortalized myoblast cell lines and uses thereof
CA3168904A1 (en) 2020-01-27 2021-08-05 Geniphys, Inc. Biologic filler for restoring and regenerating tissue
CN119894553A (zh) 2022-09-02 2025-04-25 苏黎世大学 注射装置
EP4622706A1 (en) 2022-11-21 2025-10-01 Ecole Polytechnique Fédérale de Lausanne (EPFL) System for control of spasticity
AU2023401285A1 (en) 2022-12-01 2025-07-17 Universität Zürich Method of preparing a mass culture of muscle precursor cells (mpcs) and uses thereof
JP2025041170A (ja) * 2023-09-13 2025-03-26 昌毅 本田 肛門狭窄化治療法

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4424208A (en) 1982-01-11 1984-01-03 Collagen Corporation Collagen implant material and method for augmenting soft tissue
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
US5902741A (en) * 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US5510254A (en) * 1986-04-18 1996-04-23 Advanced Tissue Sciences, Inc. Three dimensional cell and tissue culture system
US5053050A (en) * 1988-04-29 1991-10-01 Samuel Itay Compositions for repair of cartilage and bone
US5130141A (en) * 1988-05-24 1992-07-14 Law Peter K Compositions for and methods of treating muscle degeneration and weakness
US5082670A (en) * 1988-12-15 1992-01-21 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
US5045601A (en) * 1989-06-13 1991-09-03 Biointerface Technologies, Inc. Pressure-sensitive adhesive compositions suitable for medical uses
US5538722A (en) 1989-06-13 1996-07-23 Stanford University Isolation, growth, differentiation and genetic engineering of human muscle cells
EP0502081B1 (en) 1989-11-24 1996-05-22 Monash University Proliferative action of leukaemia inhibitory factor on satellite cells
US5206028A (en) * 1991-02-11 1993-04-27 Li Shu Tung Dense collagen membrane matrices for medical uses
US6497872B1 (en) * 1991-07-08 2002-12-24 Neurospheres Holdings Ltd. Neural transplantation using proliferated multipotent neural stem cells and their progeny
JP3004724B2 (ja) * 1992-04-06 2000-01-31 ユーロプラスティ インコーポレイテッド ミクロ粒子注入による逆流障害の処置
CA2144059A1 (en) 1992-09-28 1994-04-14 Patrick Aebischer Chitosan matrices for encapsulated cells
JP2995090B2 (ja) 1993-03-19 1999-12-27 キユー・メド・アクチエボラーグ 組織増大のための組成物および方法
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US6001654A (en) * 1994-01-28 1999-12-14 California Institute Of Technology Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors
US5656478A (en) * 1994-02-25 1997-08-12 The Regents Of The University Of California Smooth muscle tissue formation in vivo using cultured smooth muscle cells combined with an extracellular matrix
US6174333B1 (en) * 1994-06-06 2001-01-16 Osiris Therapeutics, Inc. Biomatrix for soft tissue regeneration using mesenchymal stem cells
US5516532A (en) * 1994-08-05 1996-05-14 Children's Medical Center Corporation Injectable non-immunogenic cartilage and bone preparation
US5594032A (en) * 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA
SG74036A1 (en) * 1994-12-13 2000-07-18 Peter K Law Instrument for cell culture
US7141072B2 (en) * 1998-10-05 2006-11-28 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method for promoting regeneration of surface cartilage in a damaged joint using multi-layer covering
US5833978A (en) * 1995-03-16 1998-11-10 Universite Laval Method of in vitro preconditioning healthy donor's myoblasts before transplantation thereof in compatible patients suffering of recessive myopathies like muscular dystrophy, for improving transplantation success
US5733337A (en) * 1995-04-07 1998-03-31 Organogenesis, Inc. Tissue repair fabric
US6121042A (en) * 1995-04-27 2000-09-19 Advanced Tissue Sciences, Inc. Apparatus and method for simulating in vivo conditions while seeding and culturing three-dimensional tissue constructs
US5855610A (en) * 1995-05-19 1999-01-05 Children's Medical Center Corporation Engineering of strong, pliable tissues
AU706026B2 (en) * 1995-06-06 1999-06-10 Case Western Reserve University Myogenic differentiation of human mesenchymal stem cells
US5591444A (en) 1995-07-28 1997-01-07 Isolagen Technologies, Inc. Use of autologous dermal fibroblasts for the repair of skin and soft tissue defects
US5869041A (en) * 1996-01-12 1999-02-09 The Miriam Hospital Delivery of bioactive compounds to an organism
US6200606B1 (en) * 1996-01-16 2001-03-13 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration
US5858351A (en) * 1996-01-18 1999-01-12 Avigen, Inc. Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors
US5876447A (en) 1996-02-14 1999-03-02 Implantech Associates Silicone implant for facial plastic surgery
US5842477A (en) * 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
US6299905B1 (en) * 1996-04-16 2001-10-09 Depuy Orthopaedics, Inc. Bioerodable polymeric adhesives for tissue repair
US5895745A (en) * 1996-09-25 1999-04-20 W.R. Grace & Co.-Conn. Method of thawing cryopreserved cells
US6150338A (en) 1997-02-13 2000-11-21 Albert Einstein College Of Medicine Of Yeshiva University Gene therapy for alleviating erectile dysfunction
WO1998044142A1 (en) 1997-04-01 1998-10-08 The General Hospital Corporation Molecular marker for muscle stem cells
US6110459A (en) 1997-05-28 2000-08-29 Mickle; Donald A. G. Transplants for myocardial scars and methods and cellular preparations
US6099832A (en) * 1997-05-28 2000-08-08 Genzyme Corporation Transplants for myocardial scars
US20020068048A1 (en) * 1997-09-05 2002-06-06 Patrick A. Dreyfus Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
US6171340B1 (en) * 1998-02-27 2001-01-09 Mcdowell Charles L. Method and device for regenerating cartilage in articulating joints
WO1999044643A1 (en) * 1998-03-06 1999-09-10 Biosepra Medical Inc. Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles
AU749675B2 (en) * 1998-03-13 2002-07-04 Mesoblast International Sarl Uses for human non-autologous mesenchymal stem cells
PT1066052E (pt) 1998-03-18 2006-06-30 Osiris Therapeutics Inc Celulas estaminais mesenquimatosas para a prevencao e tratamento
US6866842B1 (en) * 1998-05-01 2005-03-15 University Of Pittsburgh Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction
US7115417B1 (en) * 1998-05-01 2006-10-03 Chancellor Michael B Soft tissue and bone augmentation and bulking utilizing muscle-derived progenito compositions, and treatments thereof
ES2319660T3 (es) * 1998-05-01 2009-05-11 University Of Pittsburgh Uso de mioblastos en la fabricacion de un medicamento para tratar la incontinencia urinaria de esfuerzo.
WO1999056786A1 (de) 1998-05-05 1999-11-11 Institut für Diagnostikforschung GmbH an der Freien Universität Berlin Diagnostisches mittel 2 oder 3 komponenten für die mr-diagnostik
AU753773B2 (en) * 1998-06-05 2002-10-31 Organogenesis Inc. Bioengineered vascular graft prostheses
US6190893B1 (en) 1998-09-18 2001-02-20 Massachusetts Institute Of Technology Electroactive materials for stimulation of biological activity of bone marrow stromal cells
WO2000029552A1 (en) 1998-11-16 2000-05-25 Osiris Therapeutics, Inc. Alginate layer system for chondrogenic differentiation of human mesenchymal stem cells
JP2000287683A (ja) 1999-04-08 2000-10-17 Frontier:Kk ニューロン生存活性を有する筋由来成分およびｒｎａ
US6328762B1 (en) * 1999-04-27 2001-12-11 Sulzer Biologics, Inc. Prosthetic grafts
US6306424B1 (en) * 1999-06-30 2001-10-23 Ethicon, Inc. Foam composite for the repair or regeneration of tissue
WO2001019966A2 (en) 1999-09-14 2001-03-22 Children's Medical Center Corporation, The Isolation of muscle-derived stem cells and uses therefor
ATE423517T1 (de) * 1999-12-03 2009-03-15 Univ Leeds Wiederherstellung von beschädigtem gewebe
US6368859B1 (en) * 1999-12-29 2002-04-09 Children's Medical Center Corporation Methods and compositions for producing a fascial sling
EP1272204B1 (en) 2000-04-14 2007-06-20 University of Pittsburgh Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
AU2006202380B2 (en) 2000-04-14 2007-06-21 University Of Pittsburgh Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
WO2001080828A2 (en) * 2000-04-20 2001-11-01 Rtp Pharma Inc. Improved water-insoluble drug particle process
FR2810045B1 (fr) * 2000-06-07 2004-09-03 Assist Publ Hopitaux De Paris Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
EP1341475A1 (en) * 2000-12-01 2003-09-10 Nephros Therapeutics, Inc. Intravascular blood conditioning device and use thereof
EP1372398B1 (en) * 2001-02-23 2013-07-10 The University of Pittsburgh Rapid preparation of stem cell matrices for use in tissue and organ treatement and repair
CA2338124C (en) 2001-02-26 2010-08-03 Valerie Dumont Dicianna Self-tanning composition in sheeted substrate
WO2002083864A2 (en) 2001-04-13 2002-10-24 Anterogen Co., Ltd. Methods and reagents for cell transplantation
AU2003266282A1 (en) 2002-07-30 2004-02-23 Tigenix N.V. Compositions comprising muscle progenitor cells and uses thereof
DE602004029349D1 (de) 2003-04-25 2010-11-11 Univ Pittsburgh Von muskeln stammende zellen (mdcs) zur förderung und verbesserung der nervenreparatur und -regeneration
JP5668208B2 (ja) * 2004-08-16 2015-02-12 セルリサーチ コーポレイション ピーティイー リミテッド 臍帯羊膜からの幹／前駆細胞の単離
JP2008545008A (ja) * 2005-06-30 2008-12-11 プロシディオン・リミテッド Ｇｐｃｒアゴニスト
JP5395672B2 (ja) * 2006-11-28 2014-01-22 ユニバーシティー オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション 心臓病理学を処置するための筋肉由来の細胞およびその作製法および使用法
WO2008076435A1 (en) 2006-12-18 2008-06-26 University Of Pittsburgh Muscle derived cells for the treatment of gastro-esophageal pathologies and methods of making and using the same
WO2008086040A1 (en) 2007-01-11 2008-07-17 University Of Pittsburgh Muscle derived cells for the treatment of urinary tract pathologies and methods of making and using the same
TW200902007A (en) 2007-05-25 2009-01-16 Astrazeneca Ab Spirocyclopropyl piperidine derivatives
AU2008263134B2 (en) 2007-05-29 2014-06-19 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Bone augmentation utilizing muscle-derived progenitor compositions, and treatments thereof
CA2734858C (en) 2008-08-18 2019-01-15 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof

Also Published As

Publication number Publication date
ATE365045T1 (de) 2007-07-15
WO2001078754A2 (en) 2001-10-25
AU5159901A (en) 2001-10-30
AU2001251599B2 (en) 2006-03-02
DE60129007T2 (de) 2008-02-28
CA2406393C (en) 2012-10-02
US20210145892A1 (en) 2021-05-20
US9499791B2 (en) 2016-11-22
EP1272204B1 (en) 2007-06-20
JP5684963B2 (ja) 2015-03-18
US20170209495A1 (en) 2017-07-27
JP2012180355A (ja) 2012-09-20
EP1272204A2 (en) 2003-01-08
CA2406393A1 (en) 2001-10-25
US20160303169A9 (en) 2016-10-20
US20090098094A1 (en) 2009-04-16
DE60129007D1 (de) 2007-08-02
ES2288946T3 (es) 2008-02-01
HK1052645A1 (en) 2003-09-26
HK1052645B (en) 2008-03-20
PT1272204E (pt) 2007-10-02
DK1272204T3 (da) 2007-09-10
JP2003531125A (ja) 2003-10-21
WO2001078754A3 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
CY1108090T1 (el) Επαυξηση και αυξηση ογκου μαλακου ιστου και οστου χρησιμοποιωντας μυο-λαμβανομενα προγονα κυτταρα, συνθεσεις και θεραπειες αυτων
SG146691A1 (en) Methods of preparing and using stem cell compositions and kits comprising the same
EA200600076A1 (ru) Композиции и способы увеличения активности теломеразы
ATE308948T1 (de) Vorrichtung zur spondylodese mit implantierten teilen
WO2005097219A3 (en) Ecm-based graft material
WO2004009767A3 (en) Cell therapy for regeneration
WO2003077864A3 (en) Methods and compositions for directing cells to target organs
NO20033177L (no) Injiserbare depotpreparater og deres anvendelse
WO2001038303A3 (fr) Analogues de la vitamine d
MX9803992A (es) Metodos para incrementar la masa de tejido muscular usando composiciones de la proteina ob.
WO2005061019A3 (en) Methods and composition for soft tissue feature reconstruction
WO2008066886A3 (en) Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same
WO2002007749A3 (en) Device providing regulated growth factor delivery for the regeneration of peripheral nerves
WO2004039832A3 (en) Leptin-related peptides
AU2002366433A1 (en) Methods and compositions for treating metabolic bone diseases relating to human endokine alpha
AU8180001A (en) Human growth hormone to stimulate mobilization of pluripotent hematopoietic stemcells
AR043918A1 (es) Reduccion del crecimiento del vello utilizando una composicion que contiene difluorometilornitina
MXPA05003818A (es) Perfilamiento de la expresion genica de muestras ffpe.
WO2008153813A8 (en) Bone augmentation utilizing muscle-derived progenitor compositions, and treatments thereof
WO2001094586A3 (en) Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof
GB2454154A (en) Aglet for attachment to a graft material
ATE462359T1 (de) Einzelfalten-vorrichtung für die fixierung von gewebe
CN102485888A (zh) 脉冲电磁场促进人脐带间充质干细胞体外成骨分化作用
WO2010022083A3 (en) Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof
TWI845678B (zh) 純化包含於海洋雙殼軟體動物的貝殼的有機礦物層中的分子的方法、包含此分子的組合物及其用途